EA201391821A1 - Гелевые композиции - Google Patents

Гелевые композиции

Info

Publication number
EA201391821A1
EA201391821A1 EA201391821A EA201391821A EA201391821A1 EA 201391821 A1 EA201391821 A1 EA 201391821A1 EA 201391821 A EA201391821 A EA 201391821A EA 201391821 A EA201391821 A EA 201391821A EA 201391821 A1 EA201391821 A1 EA 201391821A1
Authority
EA
Eurasian Patent Office
Prior art keywords
gel compositions
compositions
directed
methods
present
Prior art date
Application number
EA201391821A
Other languages
English (en)
Inventor
Хайлян Чэнь
Эндрю Сянь Чэнь
Original Assignee
АМИЛИН ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи
АСТРАЗЕНЕКА ФАРМАСЬЮТИКАЛЗ ЭлПи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by АМИЛИН ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи, АСТРАЗЕНЕКА ФАРМАСЬЮТИКАЛЗ ЭлПи filed Critical АМИЛИН ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи
Publication of EA201391821A1 publication Critical patent/EA201391821A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение направлено на композиции и способы получения фосфолипидных гелей.
EA201391821A 2011-06-09 2012-06-08 Гелевые композиции EA201391821A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161495282P 2011-06-09 2011-06-09
US201161500042P 2011-06-22 2011-06-22
PCT/US2012/041519 WO2012170796A1 (en) 2011-06-09 2012-06-08 Gel compositions

Publications (1)

Publication Number Publication Date
EA201391821A1 true EA201391821A1 (ru) 2014-05-30

Family

ID=47296468

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201391821A EA201391821A1 (ru) 2011-06-09 2012-06-08 Гелевые композиции

Country Status (12)

Country Link
US (1) US20140249077A1 (ru)
EP (1) EP2717853A4 (ru)
JP (1) JP2014520112A (ru)
KR (1) KR20140041686A (ru)
CN (1) CN103826609A (ru)
AU (1) AU2012267721A1 (ru)
BR (1) BR112013031488A2 (ru)
CA (1) CA2838739A1 (ru)
EA (1) EA201391821A1 (ru)
IL (1) IL229696A0 (ru)
MX (1) MX2013014420A (ru)
WO (1) WO2012170796A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2664700C2 (ru) 2012-05-10 2018-08-21 Пейнреформ Лтд. Депо-составы местного анестетика и способы их получения
JP5774190B1 (ja) * 2014-12-12 2015-09-09 ジーンメディカル株式会社 皮下注射用剤及び皮下注射用剤を含有する注射器の製造方法
CN108025226B (zh) * 2015-09-25 2021-06-08 康明斯过滤Ip公司 具有水乳化器的燃料过滤器系统
EP3727333A1 (en) * 2017-12-21 2020-10-28 Taiwan Liposome Company Ltd Sustained-release triptan compositions and method of use the same through subdermal route or the like

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
US7312196B2 (en) * 1997-01-08 2007-12-25 Amylin Pharmaceuticals, Inc. Formulations for amylin agonist peptides
AU2002241738A1 (en) * 2000-12-29 2002-07-16 The Trustees Of Columbia University In The City Of New York Use of iv emulsions with different triglyceride composition, particle size and apolipoprotein e for targeted tissue delivery of hydrophobic compounds
CA2612006A1 (en) * 2004-06-15 2006-01-05 Encore Therapeutics, Inc. Phospholipid compositions and methods for their preparation and use
US7871632B2 (en) * 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
US8394765B2 (en) * 2004-11-01 2013-03-12 Amylin Pharmaceuticals Llc Methods of treating obesity with two different anti-obesity agents
WO2006122183A2 (en) * 2005-05-10 2006-11-16 Cytophil, Inc. Injectable hydrogels and methods of making and using same
WO2009114959A1 (zh) * 2008-03-20 2009-09-24 中国人民解放军军事医学科学院毒物药物研究所 可注射用缓释药物制剂及其制备方法
AU2009289529B2 (en) * 2008-09-04 2015-05-28 Amylin Pharmaceuticals, Llc Sustained release formulations using non-aqueous carriers
EP2601934A1 (en) * 2009-01-22 2013-06-12 Ludwig-Maximilians-Universität München Vesicular phospholipid gels comprising proteinaceous substances

Also Published As

Publication number Publication date
WO2012170796A1 (en) 2012-12-13
BR112013031488A2 (pt) 2016-12-20
JP2014520112A (ja) 2014-08-21
CA2838739A1 (en) 2012-12-13
AU2012267721A1 (en) 2013-12-19
KR20140041686A (ko) 2014-04-04
IL229696A0 (en) 2014-01-30
EP2717853A1 (en) 2014-04-16
MX2013014420A (es) 2014-06-23
EP2717853A4 (en) 2014-11-05
US20140249077A1 (en) 2014-09-04
CN103826609A (zh) 2014-05-28

Similar Documents

Publication Publication Date Title
CY1123958T1 (el) Μεθοδος παρασκευης παραγωγων και ενδιαμεσων καρβαμοϋλπυριδονης
CY1121862T1 (el) Αντισωματα anti-phf-tau και χρησεις αυτων
EA201390929A1 (ru) Антитела к pcsk9 и способы их применения
UY34343A (es) Proteinas de unión al antígeno cd27l
EA201491811A1 (ru) АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ
EA201590993A1 (ru) Гетеродимерные иммуноглобулины
EA201391175A1 (ru) Гетеродимерные иммуноглобулины
EA201491947A1 (ru) Антитела и иммуноконъюгаты к ly6e и способы применения
EA201590868A1 (ru) Противовирусные соединения
EA202190619A1 (ru) Противовирусные соединения
EA201491357A1 (ru) Анти-lrp5 антитела и способы их применения
EA201590731A1 (ru) Антитела к гемагглютинину и способы применения
UY34822A (es) Composiciones y métodos para silenciar la expresión genética
EA201591591A1 (ru) Соединения карбазола, применяемые в качестве ингибиторов бромодомена
UY34602A (es) ?Derivados de bencimidazolil- e imidazopiridinil-metilamina?
EA201300730A1 (ru) Производные индазолилтриазола
UY34004A (es) INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO[2,3-d]PIRIMIDINA TROPOMIOSINA
UY34414A (es) Composiciones hemostáticas
EA201492002A1 (ru) Противовирусные соединения
EA201391489A1 (ru) Композиции со сниженной вязкостью
UA110813C2 (uk) Лікування ліподистрофії
EA202091397A1 (ru) Бензохинолоновые ингибиторы vmat2
UY34415A (es) Composiciones hemostáticas
UY33909A (es) Metodo para producir fibra de lignina
CY1118079T1 (el) Μεθοδος παρασκευης του αλατος l-αργινινικης περινδοπριλης